169 related articles for article (PubMed ID: 15882113)
1. Neurotensin agonists as an alternative to antipsychotics.
Boules M; Fredrickson P; Richelson E
Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
[TBL] [Abstract][Full Text] [Related]
2. Bioactive analogs of neurotensin: focus on CNS effects.
Boules M; Fredrickson P; Richelson E
Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
[TBL] [Abstract][Full Text] [Related]
3. Novel treatments of schizophrenia: targeting the neurotensin system.
Kinkead B; Nemeroff CB
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin receptor agonists and antagonists for schizophrenia.
Robertson VB; Wilson MS
Am J Psychiatry; 2005 Mar; 162(3):634; author reply 635. PubMed ID: 15741502
[No Abstract] [Full Text] [Related]
5. Current topics: brain penetrating neurotensin analog.
Boules M; Fredrickson P; Richelson E
Life Sci; 2003 Oct; 73(22):2785-92. PubMed ID: 14511764
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor agonists and antagonists for schizophrenia.
Richelson E; Fredrickson PA; Boules MM
Am J Psychiatry; 2005 Mar; 162(3):633-4; author reply 635. PubMed ID: 15741499
[No Abstract] [Full Text] [Related]
7. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
8. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin agonists: potential in the treatment of schizophrenia.
Boules M; Shaw A; Fredrickson P; Richelson E
CNS Drugs; 2007; 21(1):13-23. PubMed ID: 17190526
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
Richelson E; Boules M; Fredrickson P
Life Sci; 2003 Jun; 73(6):679-90. PubMed ID: 12801589
[TBL] [Abstract][Full Text] [Related]
11. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Binder EB; Kinkead B; Owens MJ; Kilts CD; Nemeroff CB
J Neurosci; 2001 Jan; 21(2):601-8. PubMed ID: 11160439
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin analogs indications for use as potential antipsychotic compounds.
McMahon BM; Boules M; Warrington L; Richelson E
Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.
Shilling PD; Melendez G; Priebe K; Richelson E; Feifel D
Psychopharmacology (Berl); 2004 Sep; 175(3):353-9. PubMed ID: 15107967
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Fantegrossi WE; Ko MC; Woods JH; Richelson E
Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
[TBL] [Abstract][Full Text] [Related]
15. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
Bauco P; Rompré PP
Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
[TBL] [Abstract][Full Text] [Related]
16. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
Cáceda R; Kinkead B; Nemeroff CB
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
[TBL] [Abstract][Full Text] [Related]
17. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin, schizophrenia, and antipsychotic drug action.
Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
[TBL] [Abstract][Full Text] [Related]
19. Does neurotensin mediate the effects of antipsychotic drugs?
Kinkead B; Binder EB; Nemeroff CB
Biol Psychiatry; 1999 Aug; 46(3):340-51. PubMed ID: 10435199
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats.
Keiser AA; Matazel KS; Esser MK; Feifel D; Prus AJ
Exp Clin Psychopharmacol; 2014 Dec; 22(6):541-7. PubMed ID: 25222546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
